Timothy P. Walbert - Dec 31, 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role: Chairman, President and CEO, Director
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol: HZNP
Transactions as of: Dec 31, 2021
Transactions value $: -$7,551,987
Form type: 4
Date filed: 1/4/2022, 04:00 PM
Previous filing: Dec 1, 2021
Next filing: Jan 6, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$554K	+25K	+4.96%	$22.14^*	529K	Dec 31, 2021	Direct
transaction	HZNP	Ordinary Shares	Sale	-$7.29M	-67.5K	-12.74%	$108.02	462K	Dec 31, 2021	Direct	F1, F2
transaction	HZNP	Ordinary Shares	Sale	-$817K	-7.52K	-1.63%	$108.55	454K	Dec 31, 2021	Direct	F1, F3
holding	HZNP	Ordinary Shares						108K	Dec 31, 2021	See footnote	F4
holding	HZNP	Ordinary Shares						100K	Dec 31, 2021	See footnote	F5
holding	HZNP	Ordinary Shares						31.2K	Dec 31, 2021	By spouse

Showing 1 to 6 of 6 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Stock Option (Right to Buy)	Options Exercise	$0	-25K	-2.4%	$0.00	1.02M	Dec 31, 2021	Ordinary Shares	25K	$22.14	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.475 to $108.465 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F5	The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F6	The stock option is fully vested and exercisable.